Andreas began his career in academic research, specialising in experimental fluid dynamics in the Department of Mechanical and Aerospace Engineering at Monash University in Melbourne, Australia. His pioneering work in wind-tunnel quantification and advanced imaging of gas and liquid flow established him as an emerging leader in the field.

After completing his Master’s and PhD, Andreas rapidly progressed to Professor of Mechanical and Aerospace Engineering and Director of the Laboratory for Dynamic Imaging at Monash University. His research attracted significant recognition and funding from leading research institutions in Australia and the United States.

Leveraging this deep expertise in fluid dynamics, Andreas translated novel imaging techniques into clinical medicine through the development of XV Technology, which uniquely measures airflow within the lungs throughout the entire breathing cycle. This innovation underpins 4DMedical’s CT:VQ™ technology—a software-only solution that transforms standard CT scans into functional lung imaging, delivering quantitative ventilation and perfusion data to support clinical decision-making in respiratory disease.

Andreas’ research contributions include more than 100 peer-reviewed publications and more than 80 granted patents and patent applications.

He founded 4DMedical in December 2012 with a clear vision to ensure his research translated into meaningful patient impact globally. Since achieving FDA clearance for CT:VQ™, Andreas has led the company’s transition from research to commercial scale, securing adoption and partnerships with leading academic medical centres, major health networks, and healthcare providers across North America and internationally.

A recognised leader in medical technology innovation, Andreas remains focused on driving 4DMedical’s global commercialisation strategy and establishing its respiratory imaging solutions as a new standard of care worldwide.